AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 MAR 13 - (NewsRx.com & NewsRx.net) -- Plexus Vaccine, Inc., has won a competitive Department of Defense grant. The award provides R&D funding that enables Plexus Vaccine to acquire proof of concept for vaccine development for the biowarfare target, Yersinia pestis, and associated platform technology.
Yersinia pestis is the bacterium that causes the plague.
The award was administered by the Center for the Commercialization of Advanced Technologies .
Plexus Vaccine also will receive services, including market studies and business development support, to help the company ...